Pramlintide
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
AstraZeneca · Phase 2 · Completed · Enrollment 274
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| 1 | 3 participants | 0 participants | 1 participants | n/r | n/r |
| 2 | 2 participants | 0 participants | 2 participants | n/r | n/r |
| 3 | 5 participants | 0 participants | 1 participants | n/r | n/r |
| 4 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.